18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial-Reference-Cited by-同舟云学术

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

Published:2010-08-04 Issue:3 Volume:68 Page:319-329
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Vandenberghe Rik,Van Laere Koen,Ivanoiu Adrian,Salmon Eric,Bastin Christine,Triau Eric,Hasselbalch Steen,Law Ian,Andersen Allan,Korner Alex,Minthon Lennart,Garraux Gaëtan,Nelissen Natalie,Bormans Guy,Buckley Chris,Owenius Rikard,Thurfjell Lennart,Farrar Gill,Brooks David J.

Funder

GE Healthcare (GEHC)

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference32 articles.

1. The binding of 2-(4' methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component;Klunk;J Neurosci,2003

2. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B;Klunk;Ann Neurol,2004

3. PIB is a non-specific imaging marker of Aβ peptide-related cerebral amyloidosis;Lockhart;Brain,2007

4. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease;Ikonomovic;Brain,2008

5. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with 11C-labeled Pittsburgh compound B;Leinonen;Arch Neurol,2008

Cited by 595 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visual assessments of 11C-Pittsburgh compound-B PET vs. 18F-flutemetamol PET across the age spectrum;Nuclear Medicine Communications;2024-09-13

2. Alzheimer’s disease biomarkers and their current use in clinical research and practice;Molecular Psychiatry;2024-09-04

3. Automated Synthesis of [¹¹C]PiB via [¹¹CH₃OTf]-as Methylating Agent for PET Imaging of β-Amyloid;Current Radiopharmaceuticals;2024-09

4. Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau PET Tracers in Nuclear Medicine;Current Radiopharmaceuticals;2024-07-19

5. Verification of the effect of data-driven brain motion correction on PET imaging;PLOS ONE;2024-07-05